ArticleJournal of anesthesia2026
Antepartum hemoglobin concentrations and postpartum patient-reported outcomes: a retrospective study.
Article in Journal of anesthesia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Midazolam premedication: shaping pediatric perioperative outcomes.Journal of anesthesia · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to evaluate the association between antepartum hemoglobin concentration and postpartum recovery among women receiving obstetric anesthesia care.
methodsWe included pregnant women aged ≥ 18 years who underwent cesarean delivery (CD) or vaginal delivery (VD) with epidural analgesia (EA). The primary outcome was the Obstetric Quality of Recovery (ObsQoR)-11 score. Associations between antepartum hemoglobin concentration and ObsQoR-11 scores were evaluated using multivariable regression analyses in the overall cohort and separately in women undergoing CD and those undergoing VD with EA. Because no validated cutoff value exists for the ObsQoR-11 score, exploratory analyses were performed to examine the association between antepartum hemoglobin concentration and poor recovery, defined as an ObsQoR-11 score one standard deviation below the mean.
resultsAmong the 466 women included in the final analysis, the mean (standard deviation) ObsQoR-11 score on postpartum day 1 was 67.4 (20.8). After adjustment, antepartum hemoglobin concentration was associated with a higher ObsQoR-11 score (regression coefficient, 1.9; 95% confidence interval [CI] 0.27-3.54) and lower odds of poor recovery (odds ratio [OR], 0.74; 95% CI 0.57-0.96). These associations were observed among women undergoing CD (regression coefficient, 2.0; 95% CI 0.03-4.04; OR, 0.72; 95% CI 0.55-0.95) but not clearly demonstrated among women undergoing VD with EA (regression coefficient, 1.7; 95% CI - 1.2-4.7; OR, 0.96; 95% CI 0.41-2.25).
conclusionHigher antepartum hemoglobin concentrations were associated with higher ObsQoR-11 scores and better early postpartum recovery, mainly after CD; the association was not clearly demonstrated after VD with EA.
Indexed as
Identifiers
42360449What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.